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Introduction
High-energy trauma often produces complex limb injuries and large segmental bone defects. While several techniques have been employed to manage large bone defects, there is controversy regarding the optimal treatment. one promising approach, the two-stage Masquelet technique (the polymethylmethacrylate (pMMA)-induced biomembrane or 'induced membrane'), has demonstrated moderate success in small clinical series. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] The first stage of the technique involves the development of an induced membrane layer of cells around surgically placed methacrylate spacers placed in a segmental bone defect. in the second stage, the spacers are removed, leaving behind the encasing biomembrane into which autologous cancellous bone grafts or other inductive and/or conductive materials may then be placed.
Few studies have attempted to characterise the biological properties of the human biomembrane, 14 and the broad extent of its clinical potential in treatment of segmental bone defects remains to be fully explored. Aho et al 14 examined histological properties of the biomembrane in 14 subjects and concluded that it consisted of mature vascularised fibrous tissue with some time-sensitive osteogenic and chondrogenic potential. The purpose of the present work was to evaluate the cell biology and stem cell content of the human biomembrane formed during the Masquelet technique for treatment of segmental bone loss. This study specifically explored the morphologic, stem cell, molecular and gene expression features. improved understanding of the biological properties of the biomembrane will facilitate development of methods to optimise bone defect reconstruction strategies.
Materials and Methods
This study was performed following institutional review Board approval. The need for informed consent was waived by the ethical board as the biomembrane tissue was sampled for tissue culture as part of routine surgical practice. Biomembrane tissue was harvested during the routine surgical removal of pMMA spacers in the second stage of the Masquelet technique performed by one of the senior authors (MJB) and transported to the laboratory in sterile media where it was subdivided for studies described below. Histology and immunohistochemical analysis. Biomembrane fragments were processed for routine histological studies using haematoxylin and eosin (H&E) and Masson trichrome staining. Trabecular bone was identified by direct visualisation at ×200 magnification, by two reviewers. immunolocalisation for bone morphogenetic protein (BMp)2 and runt-related transcription factor (rUNX)2 used the antiBMp2 antibody (Bioworld Technology, inc., Saint louis park, Minnesota) at a 1:50 dilution and the anti-rUNX2 antibody (anti-rUNX2 monoclonal antibody, Abnova Corporation, Taipei, Taiwan) at a 1:100 dilution. Endogenous peroxidase was blocked using 3% H 2 o 2 (Sigma-Aldrich, St louis, Missouri). Universal rabbit Negative Control and Mouse igG (both Dako, Carpinteria, California) were used as negative controls for BMp2 and rUNX2, respectively. The secondary reagent was vector immprESS reagent, rabbit (vector laboratories inc., Burlingame, California) for 30 minutes, followed by diaminobenzidine (DAB) (Dako) for five minutes. Slides were rinsed in water, counterstained with light green, dehydrated, cleared and mounted with resinous mounting media. Cell differentiation analyses. Cells were cultured in monolayer from biomembrane fragments and used to test for stem cell potency using defined media, which allow differentiation to osteogenic, chondrogenic and adipogenic phenotypes using methods previously reported by our laboratory. 15, 16 Differentiation of osteogenic cells was performed using the osteogenesis Kit (lonza Group AG, Basel, Switzerland) 17 and assessed with positive alizarin red (Sigma-Aldrich) staining of mineralised matrix following 21 to 28 days of culture. Biomembrane cells were seeded at a density of 50 000 cells/well in a 24-well tissue culture plate, established in culture for between one and nine days, and then supplemented with the kit's osteogenic Differentiation Media. Biomembrane cells were differentiated to adipogenic cells using the Mesenchymal Stem Cell Adipogenic Differentiation medium (lonza); differentiated cells were stained with oil red o (Sigma-Aldrich) to demonstrate fat droplets.
Demonstration of chondrogenic differentiation was based on micromass in vitro formation by cells cultured for two to 18 days in Chondrogenic induction Medium (lonza), supplemented with 5% foetal bovine serum (FBS) and 10 ng/ml transforming growth factor-ß3 (TGF-β3). Cells were seeded at a density of 200 000 cells/ well in a 24-well tissue culture plate and supplemented three times a week. Control cultures were supplemented with MSCBM (Mesenchymal Stem Cell Basal Medium, lonza) basal media only. Control and differentiating cultures were supplemented three times per week. Digital images were used to document cell differentiations in vitro. Human foetal osteoblast culture. The human osteoblast cell line hFoB 1.19 was obtained from the American Type Culture Collection (ATCC; Manassas, virginia). Cells were grown in a 24-well tissue culture plate at 33.5° C, 95% humidity, and 5% Co 2 with Dulbecco's Modified Eagle's Medium (DMEM)/Ham's F10 medium: 1:1 ratio DMEM/Ham's F12 with l-glutamine (DMEM/F12; life Technologies, Carlsbad, California), 10% FBS (Atlas Biologicals, Fort Collins, Colorado), 0.3 mg/ml G418 (Geneticin r; life Technologies). once confluent, the growth medium was switched to differentiation media which consisted of DMEM/Ham's F10 with 0.1 mg/ml l-ascorbic acid, 10 −8 M menadione, 5 mM ß-glycerol phosphate, and 10 −7 M 1α,25-Dihydroxyvitamin D3 (SigmaAldrich). This differentiation methodology and this cell line have been previously described. 18, 19 Cells were incubated at 39.5° C for seven days. To confirm osteoblast differentiation, wells were stained for bone mineralisation via alizarin red (data not shown). Microarray gene expression studies. mrNA was harvested from biomembrane specimens following homogenisation; mrNA from the biomembrane and from cultured osteoblasts using Trizol (life Technologies). Affymetrix microarray analyses were used to compare gene expression patterns of the biomembrane with cultured osteoblast cells (HG-U133 + pM strips; Affymetrix inc., Santa Clara, California). Affymetrix '.cel' files were uploaded to GeneSifter web-based software (vizX labs, Seattle, Washington), normalised, and statistical significance determined (p < 0.05) using the unpaired student t-test (two-tailed). Data were corrected for false discovery rates using the Benjamini-Hochberg test and results are expressed as fold changes (2.0 and greater only). ontology searches (which allow one to avoid searching gene by gene and also provide a controlled vocabulary of search terms for gene characteristics) were used for the following bone-related ontology groupings: angiogenesis and related vascularity categories; collagen; bone development; bone remodeling; negative regulation of bone remodeling; positive regulation of bone remodeling; regulation of bone remodeling; bone resorption; BMp signaling pathway; ossification; regulation of osteoblast differentiation; positive regulation of osteoblast differentiation; osteoblast differentiation; osteoblast development; negative regulation of osteoclast differentiation; positive regulation of osteoclast differentiation; regulation of osteoclast differentiation; osteoclast differentiation; chondrocyte differentiation; chondrocyte development; cartilage development, and the following ontologies for stem cells: differentiation, division, regulation of stem cell division, maintenance, and canonical WNT receptor signaling pathway involved in mesenchymal stem cell differentiation.
An additional analysis of gene expression patterns was carried out, which used the ontology groups described above to test for differences in major bone-, cartilageand vascular-related genes in specimens with longer spacer duration periods (> 12 weeks) versus specimens with shorter spacer durations. Statistical analysis. For non-microarray data analysis, standard statistical methods were used employing inStat (Graphpad Software, inc., San Diego, California). Means and standard deviation (sd) were calculated, and p < 0.05 was set as the significance level. Spearman's correlation was used to test for linear relationships between the presence (scored as one) or absence (scored as two) of trabecular bone within the biomembrane histological specimen and the duration of the pMMA spacer in the surgical site.
Results
Subjects. Demographic and clinical features of the study population are presented in Table i . Biomembrane specimens were obtained from 12 surgeries for complex fractures (mean age 40.7 years, sd 14.4; four women, eight men) resulting from six motor vehicle or motorcycle accidents, four falls, and two gunshot wounds. Table i presents data on the surgical site, low-or highenergy causes for the trauma, the presence or absence of infection, the length of the bony defect, the volume of the pMMA spacer, and Arbeitsgemeinschaft für osteosynthesefragen/American orthopaedic Trauma Association (Ao/oTA) classification 20 and the Gustilo classification. 21 The mean duration of the pMMA spacers within the patient fracture sites was 11.9 weeks (six to 18). radiographic measurements (in cm) were performed using Ap and lateral radiographs of fractures at the time of fixation during pMMA spacer placement. lengths, widths and depths were obtained and data used to calculate the approximate pMMA spacer volume (in cm 3 ) (Table i ). in total, 50% of the subjects had bone infections at the time of pMMA spacer placement (Table i) .
Morphological features of the human biomem-
brane. Biomembrane tissues examined with routine histology showed the presence of trabecular bone in four out of 12 (33.3%) of the biomembrane specimens ( Fig. 1 ). There was no correlation between the presence of trabecular bone in the specimens and the duration of the pMMA spacer in the surgical site. Morphological analysis showed the presence of high collagen content and extensive vascularity (Fig. 2) . immunohistochemistry showed that the osteoinductive factor BMp2 was present in osteoblasts, osteocytes and in cells within the biomembrane stroma (Fig. 3 ). rUNX2 (also called CBFA1, a regulator of osteoblast differentiation) was also found to be present within the biomembrane (Fig. 4) . Stem cell capacity of the biomembrane. Cells cultured from the biomembrane grew well and displayed a spindle-shaped morphology in monolayer culture. positive osteogenic capacity was demonstrated in seven out of ten (70%) tested cultures (Fig. 5 ). Chondrogenic capacity was demonstrated by formation of micromasses ( Fig. 6 ) with the strong presence of chondroitin sulfate on immunohistochemistry (Fig. 7) . Chondrogenic differentiation was seen in 90.9% of specimens (11 out of 12 tested specimens). Adipogenic differentiation was demonstrated by the presence of fat droplets (Fig. 8) . Adipogenic differentiation was seen in 90% of the specimens (nine out of ten tested specimens). Additional data were gained on the stem cell features of the biomembrane by microarray analyses which compared the biomembrane to cultured osteoblasts (Table ii) . Gene expression was stronger in the biomembrane for secreted frizzled-related protein (SFrp) 2 (upregulated 77 fold), an important factor which interacts with Wnt signaling to enhance mesenchymal stem cell engraftment and myocardial repair. 22, 23 Molecular characterisation of bone-, cartilage-and vasculature-related gene expression: comparison of biomembrane expression patterns with osteoblast cell culture.
Table ii shows findings regarding the upregulation of genes in the biomembrane (in comparison with expression patterns in cultured osteoblasts) for genes related to bone and cartilage (BMp2, upregulated three-fold; BMp6, upregulated three-fold; matrix gla protein, upregulated 158-fold; and rUNX2, upregulated six-fold), and many collagen genes, including collagen type i, alpha 2. Also present were several genes related to vasculature with strong expression patterns, including angiopoietin 2 (upregulated 12-fold), and endothelial cell-specific chemotaxis regulator (upregulated five-fold).
Comparison of biomembranes with longer versus shorter
PMMA spacer residence. The second type of gene analysis performed was a comparison of genes expressed in biomembranes in spacers that resided within the host subject for > 12 weeks compared with those from spacers that had a duration of < 12 weeks (Table iii) . For spacers with longer maturation times, it was noted that there remained a modest upregulation of several genes with recognised relationships to stem cells (BMp7, MYST histone acetyltransferase 3, fibroblast growth factor (FGF) receptors 1 and 2, FGF 4 and sonic hedgehog). With respect to bone-and cartilage-related genes, upregulation was seen in oestrogen receptor 1 (upregulated 3.1-fold), growth and differentiation factor 5 (upregulated 2.4-fold) and a number of matrix-related genes. immunohistochemical localisation of runt-related transcription factor 2 within the biomembrane. insert upper right shows an adjacent section processed as a negative control (Bar = 20 µm).
Fig. 5
Biomembrane cells cultured in osteogenic differentiation media showed development of calcified nodules as verified here with alizarin red staining. insert lower right shows no development of calcified nodules in cells grown in control medium. original magnification ×200.)
Fig. 6
Biomembrane cells cultured in chondrogenesis media showed the formation of compact micromasses in vitro (diameter of the culture plate well shown is 16 mm).
Discussion
The ability to reconstruct large bone defects that occur as a result of open fractures and/or infections remains a significant challenge in orthopaedic trauma. The Masquelet technique, which uses an induced biomembrane as a conduit for bone graft, has increasingly been used in treatment of patients with complicated segmental bone loss. The purpose of this study was to investigate the cell biology and stem cell content of the human biomembrane formed during the induced biomembrane technique.
our results demonstrated that the histological presence of isolated bone islands formed with the biomembrane tissue harvested at the time of spacer removal was consistent with intramembranous ossification. This is an important finding in human biomembrane research and is similar to previous studies from our laboratory that have evaluated the properties of biomembranes formed in a rat segmental defect model. 24, 25 Stem cell differentiation analyses in the current study used cells isolated from the human biomembrane. These cells showed a greater variability in pluripotency for osteogenic potential (70%) compared with chondrogenic or adipogenic potentials (100% and 90%, respectively). Since the clinical outcome desired with the Masquelet approach is bone formation, we chose an osteoblast cell line rather than fibroblasts for comparison with the biomembrane in our gene expression analyses as osteoblasts are more relevant to expression patterns related to bone formation. Strong expression and high fold changes were found for bone-, cartilage-, stem cell-and angiogenesis-related genes (Table ii) . 22, 23 The high expression level of asporin (upregulated 208 times) merits comment. As shown in previous osteoarthritis literature, not only can this extracellular matrix protein inhibit TGF-ß and regulate chondrogenic potential with additional evidence for a role in osteoarthritis, 26, 27 but also, some research points to elevated asporin expression in osteoblasts in subchondral bone in osteoarthritic patients. 28 in the second part of our gene analysis studies, we looked for differences in expression patterns in pMMA spacers with longer versus shorter maturation periods. Upregulation of several stem cell-related genes was identified as well as bone-, cartilage-and vascular-related genes (Table iii) . Downregulation of several genes was also seen. We would postulate that this is because these genes, including type i collagen, were more actively expressed in the early biomembrane stages during formation of the stroma and islands of trabecular bone.
The biomembrane lies within a highly complex biological milieu in which many cytokine systems are active. [29] [30] [31] The biomembrane is used clinically as both a receptive bed for bone formation and a source of mesenchymal stem cells which may be recruited and directed to this bed during the healing process. Although several small animal models have been used to evaluate the biomembrane, few studies have analysed the cellular features and stem cell content of biomembranes isolated from humans. A recent paper by Aho et al 14 analysed properties of the induced biomembrane from 14 human subjects. They concluded that the biomembrane consisted of mature vascularised fibrous tissue with some osteogenic and chondrogenic time-sensitive potential. However, unlike the current study, their work did not extensively evaluate the difference in gene expression patterns of several bone-, cartilage-and vascular-related genes. The gene expression Biomembrane cells cultured for adipogenesis show the presence of fat droplets (stained red in the micrograph). insert lower right shows that biomembrane cells cultured in control media showed no presence of fat droplets (original magnification ×200).
work reported in the present study may serve as a foundation for future studies that focus on specific gene up-or down-regulation in order to optimise the biomembrane osteogenic potential.
This study has several strengths and limitations. one strength is that data presented herein are shown in relation to well characterised clinical findings, including pMMA spacer duration, energy levels of the trauma source, Ao/oTA and Gustilo classifications, fracture fixation descriptions, presence or absence of infection, and measurements of bone defect lengths and volume of the pMMA spacer (Table i) . one other important consideration and possible limitation of this study is that the biomembrane analyses presented here are based upon specimens derived from variable sites in the tibia and femur, and the biomembranes formed in response to variable pMMA spacer sizes which resided in the site for different time periods (six to 18 weeks). There was also significant variation in subject ages (18 to 62 years). These factors undoubtedly influenced important features such as vascularisation since the vascularity and healing potential in a younger subject would presumably be greater than that of a middle-aged subject. However, this variability in study population structure reflects the potential age range of trauma patients with severe large bone defects who may be effectively treated with the Masquelet technique. results from age-and site-controlled small animal studies were previously reported by our group. 24, 25 Another limitation of this study is that it has a relatively small sample size for the gene expression analyses. Although many of the differences in gene expression reached statistical significance, future studies with larger sample sizes are needed.
our findings add additional clinical cases to the literature, and advance this research by quantifying the osteogenic, chondrogenic and adipogenic differentiation potential of cells within the biomembrane. This novel work establishes baseline data for the process during which biomembrane cells differentiate into important stem cells. We look forward to such information being used in work designed to optimise the osteogenic or chondrogenic potential of the biomembrane, potentially expediting the timeline for healing segmental bone defects in patients with complex fractures.
in conclusion, the Masquelet technique (pMMAinduced biomembrane) is successfully employed in current bone defect reconstruction treatment. limited data exist on detailed characterisation of the cell biology of the human biomembrane. We suggest that future research directed towards optimising the biological features of the biomembrane should focus on optimisation of the osteogenic features of the cell population and on ways to direct the stem cells present in the biomembrane into the osteogenic lineage (25% of our biomembrane cell specimens did not differentiate into osteoblasts). This is vital since timely formation of high-quality bone is of paramount importance in the clinical patient population with segmental bone defects. The work presented herein represents an important step forward in the advancement of our understanding of the cellular features and stem cell properties of the human biomembrane and highlights the importance for future research in which biomembranes may be modified to create an optimal bone healing microenvironment. 
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